Alpha Teknova, Inc.(TKNO)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,613 of 2,962 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
TKNO Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for Alpha Teknova, Inc. (TKNO), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores TKNO at 26.6/100 on a 32-signal composite quality model, placing it at rank #2,613 of 2,962 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue scale (7.8) and balance sheet strength (12.7), which score below median versus the broader universe. Shareholder dilution risk is elevated at 18.1/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Alpha Teknova, Inc. reports quarterly revenue of $12.2M, net income of $-3.2M, free cash flow of $-596.0K. Top institutional holders of TKNO by reported 13-F value include ROYCE & ASSOCIATES, VANGUARD CAPITAL MANAGEMENT, Roubaix Capital, based on the most recent SEC filings. TKNO trades on the Nasdaq exchange and files with the SEC under CIK 1850902. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TKNO daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Alpha Teknova, Inc. directly from SEC EDGAR. Alpha Teknova, Inc.'s 13F Pro composite quality score has ranged between 12 and 35 since 2022, currently 26.6 — a declining long-term trajectory across 64 quarterly and live scoring snapshots.
Revenue
Q2 2026
$12.2M
Net Income
Q2 2026
$-3.2M
Free Cash Flow
Q2 2026
$-596.0K
ROIC
Q2 2026
-15.3%
D/E Ratio
Q2 2026
0.21
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
+7.4% YoYNet Income
+35.5% YoYOperating Income
+35.1% YoYEPS (Diluted)
+43.9% YoYTotal Assets
-12.8% YoYTotal Debt
-2.7% YoYOp. Cash Flow
+30.2% YoYFree Cash Flow
+27.5% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $40.5M +7.4% | $37.7M +2.9% | $36.7M -11.4% | $41.4M +12.3% | $36.9M +17.9% | $31.3M |
| Net Income | $-17.3M +35.5% | $-26.7M +27.3% | $-36.8M +22.5% | $-47.5M -384.2% | $-9.8M -374.6% | $3.6M |
| Operating Income | $-17.0M +35.1% | $-26.1M +26.5% | $-35.6M +28.4% | $-49.7M -313.5% | $-12.0M -357.5% | $4.7M |
| EPS (Diluted) | $-0.32 +43.9% | $-0.57 +50.9% | $-1.16 +31.4% | $-1.69 -177.0% | $-0.61 -814.3% | $0.09 |
| Total Assets | $103.6M -12.8% | $118.8M -7.6% | $128.6M -15.5% | $152.3M -8.6% | $166.5M +164.7% | $62.9M |
| Total Debt | $13.1M -2.7% | $13.5M +1.8% | $13.3M -39.7% | $22.0M +85.1% | $11.9M | $0.00 |
| Operating Cash Flow | $-8.6M +30.2% | $-12.4M +34.1% | $-18.8M +31.3% | $-27.4M -202.1% | $-9.1M -462.0% | $2.5M |
| Free Cash Flow | $-9.8M +27.5% | $-13.5M +49.5% | $-26.7M +51.8% | $-55.5M -91.9% | $-28.9M -877.6% | $-3.0M |
Get alerted when TKNO's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Alpha Teknova, Inc. including:
Top Institutional Holders of TKNO
ROYCE & ASSOCIATES LP
$9.4M1,661,395 shVANGUARD CAPITAL MANAGEMENT LLC
$9.2M1,614,045 shRoubaix Capital, LLC
$9.0M1,579,404 shBlackRock, Inc.
$5.0M879,786 shUBS Group AG
$3.6M631,967 shConestoga Capital Advisors, LLC
$1.8M314,554 shGEODE CAPITAL MANAGEMENT, LLC
$1.8M311,818 shBANK OF AMERICA CORP /DE/
$1.5M255,760 shGOLDMAN SACHS GROUP INC
$977.1K172,017 shSTATE STREET CORP
$936.5K164,885 sh
| Fund | Value | Shares |
|---|---|---|
| ROYCE & ASSOCIATES LP | $9.4M | 1,661,395 |
| VANGUARD CAPITAL MANAGEMENT LLC | $9.2M | 1,614,045 |
| Roubaix Capital, LLC | $9.0M | 1,579,404 |
| BlackRock, Inc. | $5.0M | 879,786 |
| UBS Group AG | $3.6M | 631,967 |
| Conestoga Capital Advisors, LLC | $1.8M | 314,554 |
| GEODE CAPITAL MANAGEMENT, LLC | $1.8M | 311,818 |
| BANK OF AMERICA CORP /DE/ | $1.5M | 255,760 |
| GOLDMAN SACHS GROUP INC | $977.1K | 172,017 |
| STATE STREET CORP | $936.5K | 164,885 |
Companies Similar to TKNO
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
SHOULDER INNOVATIONS, INC.
ORTHOPEDIATRICS CORP
Cryoport, Inc.
Vanda Pharmaceuticals Inc.
HARROW, INC.
Janux Therapeutics, Inc.
Caribou Biosciences, Inc.
Schrodinger, Inc.
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put TKNO on your watchlist
Track score changes the day Alpha Teknova, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is TKNO a good stock to buy?
13F Pro's AI-powered analysis of Alpha Teknova, Inc. (TKNO) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for TKNO are available on the TKNO stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. TKNO is classified as a small company.
Which hedge funds own TKNO?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling TKNO. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Alpha Teknova, Inc.'s investment landscape.